DK1878431T3 - Lægemiddel til forebyggelse af apoptotiske forandringers progression og standsning af nekrotiske forandringer i organismens væv - Google Patents
Lægemiddel til forebyggelse af apoptotiske forandringers progression og standsning af nekrotiske forandringer i organismens vævInfo
- Publication number
- DK1878431T3 DK1878431T3 DK06747757.0T DK06747757T DK1878431T3 DK 1878431 T3 DK1878431 T3 DK 1878431T3 DK 06747757 T DK06747757 T DK 06747757T DK 1878431 T3 DK1878431 T3 DK 1878431T3
- Authority
- DK
- Denmark
- Prior art keywords
- derivative
- changes
- purine
- apoptotic
- progression
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4425—Pyridinium derivatives, e.g. pralidoxime, pyridostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
- A61K31/708—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid having oxo groups directly attached to the purine ring system, e.g. guanosine, guanylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7084—Compounds having two nucleosides or nucleotides, e.g. nicotinamide-adenine dinucleotide, flavine-adenine dinucleotide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2005112851/15A RU2311180C2 (ru) | 2005-04-28 | 2005-04-28 | Средство для предотвращения прогрессирования апоптотических и купирования некротических изменений в тканях организма |
PCT/RU2006/000198 WO2006115436A1 (fr) | 2005-04-28 | 2006-04-19 | Medicament destine a la prevention de la progression de changements apoptotiques et a l'interruption de changements necrotiques dans les tissus du corps |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1878431T3 true DK1878431T3 (da) | 2011-06-06 |
Family
ID=37214997
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK06747757.0T DK1878431T3 (da) | 2005-04-28 | 2006-04-19 | Lægemiddel til forebyggelse af apoptotiske forandringers progression og standsning af nekrotiske forandringer i organismens væv |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1878431B1 (da) |
AT (1) | ATE504304T1 (da) |
DE (1) | DE602006021167D1 (da) |
DK (1) | DK1878431T3 (da) |
EA (1) | EA014753B1 (da) |
GE (1) | GEP20104911B (da) |
PT (1) | PT1878431E (da) |
RU (1) | RU2311180C2 (da) |
WO (1) | WO2006115436A1 (da) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2671200C2 (ru) * | 2015-12-07 | 2018-10-30 | Закрытое Акционерное Общество "Фармфирма "Сотекс" | Способ получения 6-метил-2-этилпиридин-3-ол соли (2S)-2-ацетаминопентандиовой кислоты |
RU2664453C1 (ru) * | 2017-11-24 | 2018-08-17 | федеральное государственное бюджетное образовательное учреждение высшего образования "Тверской государственный медицинский университет" Министерства здравоохранения Российской Федерации | Производное 3-гидроксипиридина с анксиолитической и ноотропной активностью |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU98104073A (ru) * | 1995-09-14 | 2000-01-27 | Эл-Экс-Ар Биотекнолоджи Инк. | Композиция, обладающая антиапоптотической активностью, содержащая смесь фосфолипидов |
US5668114A (en) * | 1996-05-08 | 1997-09-16 | Birkmayer Pharmaceuticals | NADH and NADPH pharmaceuticals for treating hypertension |
AR016551A1 (es) * | 1997-07-30 | 2001-07-25 | Smithkline Beecham Corp | Derivados de 2-oxindol, composiciones farmaceuticas que los comprenden y el uso de los mismos para la manufactura de medicamentos |
US6514983B1 (en) * | 1997-09-03 | 2003-02-04 | Guilford Pharmaceuticals Inc. | Compounds, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage |
RU2168993C1 (ru) * | 2000-05-11 | 2001-06-20 | Михин Вадим Петрович | Средство для лечения нестабильной стенокардии и острого инфаркта миокарда |
RU2205640C1 (ru) * | 2002-04-09 | 2003-06-10 | Общество с ограниченной ответственностью "Экофарминвест" | Стабильный фармацевтический состав, содержащий мексидол |
AU2003264195A1 (en) * | 2002-09-03 | 2004-03-29 | Neurological Technologies Inc. | Use of guanosine or inosine as anti-apoptotic agents in the treatment of i. a. neurodegenerative diseases or injuries at the nervous system |
EP1638579A2 (en) * | 2003-07-02 | 2006-03-29 | Emory University | Compositions and methods for use of a protease inhibitor and adenosine for preventing organ ischemia and reperfusion injury |
RU2250210C1 (ru) * | 2003-07-25 | 2005-04-20 | Институт Проблем Химической Физики Российской Академии Наук (Ипхф Ран) | Нитроксисукцинат 2,4,6-триметил-3-оксипиридина и способ его получения |
-
2005
- 2005-04-28 RU RU2005112851/15A patent/RU2311180C2/ru not_active IP Right Cessation
-
2006
- 2006-04-19 EP EP06747757A patent/EP1878431B1/en active Active
- 2006-04-19 EA EA200702356A patent/EA014753B1/ru not_active IP Right Cessation
- 2006-04-19 PT PT06747757T patent/PT1878431E/pt unknown
- 2006-04-19 WO PCT/RU2006/000198 patent/WO2006115436A1/ru active Application Filing
- 2006-04-19 DK DK06747757.0T patent/DK1878431T3/da active
- 2006-04-19 GE GEAP200610398A patent/GEP20104911B/en unknown
- 2006-04-19 AT AT06747757T patent/ATE504304T1/de not_active IP Right Cessation
- 2006-04-19 DE DE602006021167T patent/DE602006021167D1/de active Active
Also Published As
Publication number | Publication date |
---|---|
EA200702356A1 (ru) | 2008-04-28 |
EP1878431B1 (en) | 2011-04-06 |
EP1878431A1 (en) | 2008-01-16 |
PT1878431E (pt) | 2011-06-30 |
EP1878431A4 (en) | 2009-05-27 |
GEP20104911B (en) | 2010-03-10 |
RU2311180C2 (ru) | 2007-11-27 |
RU2005112851A (ru) | 2006-11-10 |
DE602006021167D1 (de) | 2011-05-19 |
EA014753B1 (ru) | 2011-02-28 |
ATE504304T1 (de) | 2011-04-15 |
WO2006115436A1 (fr) | 2006-11-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2361993T5 (es) | Tratamiento con enzimas de productos alimenticios para celiaquía | |
CY2016031I1 (el) | Τοπικη φαρμακοτεχνικη μορφη ιβερμεκτινης για την θεραπεια δερματολογικων καταστασεων | |
MA28921B1 (fr) | Derive heterocyclique azote et medicament le contenant en tant que principe actif | |
EA200501095A1 (ru) | Фенилацетамиды и их применение в качестве модуляторов глюкокиназы | |
NO20080855L (no) | Behandling med azetidinon-baserte kolesterol absorpsjonsinhibitorer og omega-3 fettsyrer og et kombinasjonsprodukt derav | |
ECSP066371A (es) | 2,4-pirimidinadiaminas útiles en el tratamiento de enfermedades neoplásicas, desórdenes del sistema inmune e inflamatorios | |
AR027355A1 (es) | Acidos tiazolidincarboxilicos | |
DE60336664D1 (de) | Nichtnukleosidische reverse-transkriptase-hemmer | |
BR0207726A (pt) | Sais farmacêuticos | |
BRPI0509172A (pt) | pelo menos uma entidade quìmica, composição farmacêutica, métodos para tratar um paciente, para inibir pelo menos uma enzima que utiliza atp, e para tratar pelo menos uma doença, uso de pelo menos uma entidade quìmica, e, método para a fabricação de um medicamento | |
ATE344226T1 (de) | Aspirin-ausgelöste lipidmediatoren | |
AR050717A1 (es) | Composiciones farmaceuticas | |
RS52651B (en) | PHARMACEUTICAL COMPOSITION CONTAINING GESTAGENS AND / OR ESTROGENS AND 5-METHYL- (6S) -TETRAHYDROPHOLATE | |
AR057946A1 (es) | Formulacion de zonisamida de liberacion sostenidda | |
UY29648A1 (es) | Derivados de piridopirimidina, composiciones farmacéuticas que los contienen, procedimientos de preparación y aplicaciones | |
NO20006430L (no) | Neurobeskyttende sammensetning for forhindring og/eller behandling av nerve- og atferdsforandringer på grunn av angsttilstander eller depresjoner | |
AR034343A1 (es) | Combinaciones farmaceuticas | |
AR051144A1 (es) | Procedimiento para formar atorvastatina amorfa | |
BRPI0518785A2 (pt) | composto de anel de 7 membros e mÉtodo de produÇço e aplicaÇço farmacÊutica do mesmo | |
BRPI0607258A2 (pt) | uso, composto, bem como formulações farmacêuticas | |
NO20092763L (no) | Isosorbid mononitrat derivater for behandling av tarmlidelser | |
BRPI0606140A2 (pt) | tiazolidinonas, preparação e uso das mesmas como medicamento | |
DK1878431T3 (da) | Lægemiddel til forebyggelse af apoptotiske forandringers progression og standsning af nekrotiske forandringer i organismens væv | |
BRPI0607976A2 (pt) | composição farmacêutica e uso de uma composição | |
ATE458748T1 (de) | Proteinbindende methotrexat-derivate und diese enthaltende arzneimittel |